Cargando…

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study

OBJECTIVE: To evaluate viral loads at different stages of disease progression in patients infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first four months of the epidemic in Zhejiang province, China. DESIGN: Retrospective cohort study. SETTING: A desig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Shufa, Fan, Jian, Yu, Fei, Feng, Baihuan, Lou, Bin, Zou, Qianda, Xie, Guoliang, Lin, Sha, Wang, Ruonan, Yang, Xianzhi, Chen, Weizhen, Wang, Qi, Zhang, Dan, Liu, Yanchao, Gong, Renjie, Ma, Zhaohui, Lu, Siming, Xiao, Yanyan, Gu, Yaxi, Zhang, Jinming, Yao, Hangping, Xu, Kaijin, Lu, Xiaoyang, Wei, Guoqing, Zhou, Jianying, Fang, Qiang, Cai, Hongliu, Qiu, Yunqing, Sheng, Jifang, Chen, Yu, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190077/
https://www.ncbi.nlm.nih.gov/pubmed/32317267
http://dx.doi.org/10.1136/bmj.m1443
_version_ 1783527619476586496
author Zheng, Shufa
Fan, Jian
Yu, Fei
Feng, Baihuan
Lou, Bin
Zou, Qianda
Xie, Guoliang
Lin, Sha
Wang, Ruonan
Yang, Xianzhi
Chen, Weizhen
Wang, Qi
Zhang, Dan
Liu, Yanchao
Gong, Renjie
Ma, Zhaohui
Lu, Siming
Xiao, Yanyan
Gu, Yaxi
Zhang, Jinming
Yao, Hangping
Xu, Kaijin
Lu, Xiaoyang
Wei, Guoqing
Zhou, Jianying
Fang, Qiang
Cai, Hongliu
Qiu, Yunqing
Sheng, Jifang
Chen, Yu
Liang, Tingbo
author_facet Zheng, Shufa
Fan, Jian
Yu, Fei
Feng, Baihuan
Lou, Bin
Zou, Qianda
Xie, Guoliang
Lin, Sha
Wang, Ruonan
Yang, Xianzhi
Chen, Weizhen
Wang, Qi
Zhang, Dan
Liu, Yanchao
Gong, Renjie
Ma, Zhaohui
Lu, Siming
Xiao, Yanyan
Gu, Yaxi
Zhang, Jinming
Yao, Hangping
Xu, Kaijin
Lu, Xiaoyang
Wei, Guoqing
Zhou, Jianying
Fang, Qiang
Cai, Hongliu
Qiu, Yunqing
Sheng, Jifang
Chen, Yu
Liang, Tingbo
author_sort Zheng, Shufa
collection PubMed
description OBJECTIVE: To evaluate viral loads at different stages of disease progression in patients infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first four months of the epidemic in Zhejiang province, China. DESIGN: Retrospective cohort study. SETTING: A designated hospital for patients with covid-19 in Zhejiang province, China. PARTICIPANTS: 96 consecutively admitted patients with laboratory confirmed SARS-CoV-2 infection: 22 with mild disease and 74 with severe disease. Data were collected from 19 January 2020 to 20 March 2020. MAIN OUTCOME MEASURES: Ribonucleic acid (RNA) viral load measured in respiratory, stool, serum, and urine samples. Cycle threshold values, a measure of nucleic acid concentration, were plotted onto the standard curve constructed on the basis of the standard product. Epidemiological, clinical, and laboratory characteristics and treatment and outcomes data were obtained through data collection forms from electronic medical records, and the relation between clinical data and disease severity was analysed. RESULTS: 3497 respiratory, stool, serum, and urine samples were collected from patients after admission and evaluated for SARS-CoV-2 RNA viral load. Infection was confirmed in all patients by testing sputum and saliva samples. RNA was detected in the stool of 55 (59%) patients and in the serum of 39 (41%) patients. The urine sample from one patient was positive for SARS-CoV-2. The median duration of virus in stool (22 days, interquartile range 17-31 days) was significantly longer than in respiratory (18 days, 13-29 days; P=0.02) and serum samples (16 days, 11-21 days; P<0.001). The median duration of virus in the respiratory samples of patients with severe disease (21 days, 14-30 days) was significantly longer than in patients with mild disease (14 days, 10-21 days; P=0.04). In the mild group, the viral loads peaked in respiratory samples in the second week from disease onset, whereas viral load continued to be high during the third week in the severe group. Virus duration was longer in patients older than 60 years and in male patients. CONCLUSION: The duration of SARS-CoV-2 is significantly longer in stool samples than in respiratory and serum samples, highlighting the need to strengthen the management of stool samples in the prevention and control of the epidemic, and the virus persists longer with higher load and peaks later in the respiratory tissue of patients with severe disease.
format Online
Article
Text
id pubmed-7190077
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71900772020-05-01 Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study Zheng, Shufa Fan, Jian Yu, Fei Feng, Baihuan Lou, Bin Zou, Qianda Xie, Guoliang Lin, Sha Wang, Ruonan Yang, Xianzhi Chen, Weizhen Wang, Qi Zhang, Dan Liu, Yanchao Gong, Renjie Ma, Zhaohui Lu, Siming Xiao, Yanyan Gu, Yaxi Zhang, Jinming Yao, Hangping Xu, Kaijin Lu, Xiaoyang Wei, Guoqing Zhou, Jianying Fang, Qiang Cai, Hongliu Qiu, Yunqing Sheng, Jifang Chen, Yu Liang, Tingbo BMJ Research OBJECTIVE: To evaluate viral loads at different stages of disease progression in patients infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first four months of the epidemic in Zhejiang province, China. DESIGN: Retrospective cohort study. SETTING: A designated hospital for patients with covid-19 in Zhejiang province, China. PARTICIPANTS: 96 consecutively admitted patients with laboratory confirmed SARS-CoV-2 infection: 22 with mild disease and 74 with severe disease. Data were collected from 19 January 2020 to 20 March 2020. MAIN OUTCOME MEASURES: Ribonucleic acid (RNA) viral load measured in respiratory, stool, serum, and urine samples. Cycle threshold values, a measure of nucleic acid concentration, were plotted onto the standard curve constructed on the basis of the standard product. Epidemiological, clinical, and laboratory characteristics and treatment and outcomes data were obtained through data collection forms from electronic medical records, and the relation between clinical data and disease severity was analysed. RESULTS: 3497 respiratory, stool, serum, and urine samples were collected from patients after admission and evaluated for SARS-CoV-2 RNA viral load. Infection was confirmed in all patients by testing sputum and saliva samples. RNA was detected in the stool of 55 (59%) patients and in the serum of 39 (41%) patients. The urine sample from one patient was positive for SARS-CoV-2. The median duration of virus in stool (22 days, interquartile range 17-31 days) was significantly longer than in respiratory (18 days, 13-29 days; P=0.02) and serum samples (16 days, 11-21 days; P<0.001). The median duration of virus in the respiratory samples of patients with severe disease (21 days, 14-30 days) was significantly longer than in patients with mild disease (14 days, 10-21 days; P=0.04). In the mild group, the viral loads peaked in respiratory samples in the second week from disease onset, whereas viral load continued to be high during the third week in the severe group. Virus duration was longer in patients older than 60 years and in male patients. CONCLUSION: The duration of SARS-CoV-2 is significantly longer in stool samples than in respiratory and serum samples, highlighting the need to strengthen the management of stool samples in the prevention and control of the epidemic, and the virus persists longer with higher load and peaks later in the respiratory tissue of patients with severe disease. BMJ Publishing Group Ltd. 2020-04-21 /pmc/articles/PMC7190077/ /pubmed/32317267 http://dx.doi.org/10.1136/bmj.m1443 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Zheng, Shufa
Fan, Jian
Yu, Fei
Feng, Baihuan
Lou, Bin
Zou, Qianda
Xie, Guoliang
Lin, Sha
Wang, Ruonan
Yang, Xianzhi
Chen, Weizhen
Wang, Qi
Zhang, Dan
Liu, Yanchao
Gong, Renjie
Ma, Zhaohui
Lu, Siming
Xiao, Yanyan
Gu, Yaxi
Zhang, Jinming
Yao, Hangping
Xu, Kaijin
Lu, Xiaoyang
Wei, Guoqing
Zhou, Jianying
Fang, Qiang
Cai, Hongliu
Qiu, Yunqing
Sheng, Jifang
Chen, Yu
Liang, Tingbo
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
title Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
title_full Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
title_fullStr Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
title_full_unstemmed Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
title_short Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
title_sort viral load dynamics and disease severity in patients infected with sars-cov-2 in zhejiang province, china, january-march 2020: retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190077/
https://www.ncbi.nlm.nih.gov/pubmed/32317267
http://dx.doi.org/10.1136/bmj.m1443
work_keys_str_mv AT zhengshufa viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT fanjian viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT yufei viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT fengbaihuan viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT loubin viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT zouqianda viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT xieguoliang viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT linsha viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT wangruonan viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT yangxianzhi viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT chenweizhen viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT wangqi viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT zhangdan viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT liuyanchao viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT gongrenjie viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT mazhaohui viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT lusiming viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT xiaoyanyan viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT guyaxi viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT zhangjinming viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT yaohangping viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT xukaijin viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT luxiaoyang viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT weiguoqing viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT zhoujianying viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT fangqiang viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT caihongliu viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT qiuyunqing viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT shengjifang viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT chenyu viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy
AT liangtingbo viralloaddynamicsanddiseaseseverityinpatientsinfectedwithsarscov2inzhejiangprovincechinajanuarymarch2020retrospectivecohortstudy